10
Publications
358
Citations
10
H-Index
2011
Active since
Xuemin Zheng is an author at Tianjin Institute of Pharmaceutical Research (China) specializing in medicine, pharmacology, and biochemistry.
Top concepts
MedicinePharmacologyBiochemistryDiabetesEngineeringGlycobiologyDrug DiscoveryProtein FoldingNatural SciencesMolecular Biology
Publications per year
2011–2017
10
10
Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist
Ying Li, Xuemin Zheng, Xiulin Yi et al. · The FASEB Journal · 2017 · 78 citations · Full text
GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
Ying Li, Xuemin Zheng, Weiren Xu et al. · Peptides · 2011 · 33 citations
Rows per page
1–5 of 10